The former top innovator at the Government Accountability Office, Taka Ariga, is hopeful that the unit will remain “vanguard of experimentation and exploration” for Congress and others.
The Office of Science and Technology Policy disagreed with the watchdog’s recommendation that it should inform agencies about their status as implementing agencies with regulatory authority.
The watchdog offered a new assessment of the agency’s work to establish an active postmarket surveillance system to monitor the safety and efficacy of medical devices.
Sen. Ernst, ranking member of the chamber’s Small Business Committee, has been critical of the agency’s privacy standards around personally identifiable information.